| Catalog_no |
ADMC0529 |
| Product_name |
SKLB610 |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
1660.00/5000.00/6120.00 |
| Specificity |
TargetTargeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays. |
| Dilution |
|
| Purification |
>98% |
| Concentration |
靶点：FGFR;IC50：No data |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
SKLB 610; SKLB-610 |
| Molecular Weight |
415.37 |
| Notes |
SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays. |
| Instructions |
 查看与下载 |
